Article ; Online: Identification of novel genes by targeted exome sequencing in Retinoblastoma.
2022 Volume 43, Issue 6, Page(s) 771–788
Abstract: Background: Retinoblastoma (RB) is initiated by mutation in both alleles of : Methodology: The current study was planned to utilize targeted exome sequencing in Indian RB patients affected with unilateral non-familial RB. 75 unilateral RB patients ... ...
Abstract | Background: Retinoblastoma (RB) is initiated by mutation in both alleles of Methodology: The current study was planned to utilize targeted exome sequencing in Indian RB patients affected with unilateral non-familial RB. 75 unilateral RB patients below 5 years of age were enrolled. Genomic DNA was extracted from blood and tumor tissue. From peripheral blood DNA, all coding and exon/intron regions were amplified using PCR and direct sequencing. Cases which did not harbor pathogenic variants in peripheral blood DNA were further screened for mutations in their tumor tissue DNA using targeted exome sequencing. Three pathogenicity prediction tools (Mutation Taster, SIFT, and PolyPhen-2) were used to determine the pathogenicity of non-synonymous variations. An in-house bioinformatics pipeline was devised for the mutation screening by targeted exome sequencing. Protein modeling studies were also done to predict the effect of the mutations on the protein structure and function. Results: Using the mentioned approach, we found two novel variants (g.69673_69674insT and g.48373314C>A) in Conclusion: The present study expands our current knowledge regarding the genomic landscape of RB and also highlights the importance of NGS technologies to detect genes and novel variants that may play an important role in cancer initiation, progression, and prognosis. |
---|---|
MeSH term(s) | Humans ; Retinoblastoma/pathology ; Exome Sequencing ; Mutation ; Genes, Retinoblastoma/genetics ; DNA Mutational Analysis ; Retinal Neoplasms/pathology ; Proteins/genetics ; ADP-Ribosylation Factors/genetics ; Tumor Suppressor Proteins/genetics ; SOX Transcription Factors/genetics |
Chemical Substances | OTOR protein, human ; Proteins ; ARL11 protein, human (EC 3.6.5.2) ; ADP-Ribosylation Factors (EC 3.6.5.2) ; SOX30 protein, human ; Tumor Suppressor Proteins ; SOX Transcription Factors |
Language | English |
Publishing date | 2022-08-05 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 1199279-7 |
ISSN | 1744-5094 ; 0167-6784 ; 1381-6810 |
ISSN (online) | 1744-5094 |
ISSN | 0167-6784 ; 1381-6810 |
DOI | 10.1080/13816810.2022.2106497 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1708: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.